Conversely, CD8+ T cells from immunologically hot tumors like non-small cell lung carcinoma (NSCLC) are enriched in ICI-responsive TCF1+ PD1+ T cells. This evidence concerns the gene TCF7 and non-small cell lung carcinoma.